ATE140215T1 - 15-deoxyspergualin analoge verbindungen, verfahren zu ihrer herstellung und ihre verwendung als therapeutika zur unterdrückung der immunabwehr - Google Patents

15-deoxyspergualin analoge verbindungen, verfahren zu ihrer herstellung und ihre verwendung als therapeutika zur unterdrückung der immunabwehr

Info

Publication number
ATE140215T1
ATE140215T1 AT93402795T AT93402795T ATE140215T1 AT E140215 T1 ATE140215 T1 AT E140215T1 AT 93402795 T AT93402795 T AT 93402795T AT 93402795 T AT93402795 T AT 93402795T AT E140215 T1 ATE140215 T1 AT E140215T1
Authority
AT
Austria
Prior art keywords
deoxyspergualin
therapeutics
suppressing
production
immune defense
Prior art date
Application number
AT93402795T
Other languages
German (de)
English (en)
Inventor
Patrice Renaut
Luc Lebreton
Patrick Dutartre
Philippe Derrepas
Soth Samreth
Original Assignee
Fournier Ind & Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fournier Ind & Sante filed Critical Fournier Ind & Sante
Application granted granted Critical
Publication of ATE140215T1 publication Critical patent/ATE140215T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/12Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/24Y being a hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Soil Conditioners And Soil-Stabilizing Materials (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
AT93402795T 1992-12-02 1993-11-17 15-deoxyspergualin analoge verbindungen, verfahren zu ihrer herstellung und ihre verwendung als therapeutika zur unterdrückung der immunabwehr ATE140215T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9214517A FR2698628B1 (fr) 1992-12-02 1992-12-02 Analogues de 15-déoxyspergualine, leur procédé de préparation et leur utilisation en thérapeutique.

Publications (1)

Publication Number Publication Date
ATE140215T1 true ATE140215T1 (de) 1996-07-15

Family

ID=9436147

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93402795T ATE140215T1 (de) 1992-12-02 1993-11-17 15-deoxyspergualin analoge verbindungen, verfahren zu ihrer herstellung und ihre verwendung als therapeutika zur unterdrückung der immunabwehr

Country Status (23)

Country Link
US (1) US5476870A (enExample)
EP (1) EP0600762B1 (enExample)
JP (1) JP2945261B2 (enExample)
KR (1) KR100187328B1 (enExample)
CN (1) CN1045431C (enExample)
AT (1) ATE140215T1 (enExample)
AU (1) AU664124B2 (enExample)
CA (1) CA2110437C (enExample)
CZ (1) CZ284958B6 (enExample)
DE (1) DE69303583T2 (enExample)
DK (1) DK0600762T3 (enExample)
ES (1) ES2092263T3 (enExample)
FI (1) FI112211B (enExample)
FR (1) FR2698628B1 (enExample)
GR (1) GR3021269T3 (enExample)
HU (1) HU218908B (enExample)
NO (1) NO180483C (enExample)
NZ (1) NZ250330A (enExample)
RU (1) RU2114823C1 (enExample)
SK (1) SK280286B6 (enExample)
TW (1) TW311132B (enExample)
UA (1) UA39920C2 (enExample)
ZA (1) ZA938821B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09511765A (ja) * 1995-02-10 1997-11-25 フルニエ・アンデュストリ・エ・サンテ 15−デオキシスペルグアリン類似体、その治療用途及びその調製方法
FR2734263B1 (fr) * 1995-05-17 1997-06-20 Fournier Ind & Sante Analogues de la 15-deoxyspergualine, leur procede de preparation et leur utilisation en therapeutique
ES2139465T3 (es) * 1996-12-20 2000-02-01 Sueddeutsche Kalkstickstoff Piruvatos de creatina y procedimiento para su preparacion.
DE19728436A1 (de) * 1997-07-03 1999-01-07 Niels Franke Niedrigdosierte 15-Desoxyspergualin-Präparate
HK1043801A1 (zh) * 1998-08-28 2002-09-27 格莱风科学公司 精确长度的聚酰胺链、其制备方法和其与蛋白质的缀合物
DE19923961A1 (de) * 1999-05-25 2000-11-30 Euro Nippon Kayaku Gmbh Verwendung von 15-Deoxyspergualin zur Behandlung von hyperreaktiven entzündlichen Erkrankungen und Autoimmunerkrankungen
CA2565633C (en) * 2004-05-05 2016-04-26 Atugen Ag Lipids, lipid complexes and use thereof
WO2006069782A2 (en) 2004-12-27 2006-07-06 Silence Therapeutics Ag. Lipid complexes coated with peg and their use
WO2010074591A1 (ru) 2008-12-24 2010-07-01 Закрытое Акционерное Общество "Beptekc" Амиды креатина, способ их получения, средство, обладающее нейропротекторным действием
RU2428414C2 (ru) 2009-11-03 2011-09-10 Закрытое Акционерное Общество "Вертекс" Способ получения амидов креатина
JP5878172B2 (ja) * 2010-07-29 2016-03-08 ラボラトワール フルニエ エスアーエス 炎症性眼疾患の治療/予防用化合物
FR2963238B1 (fr) * 2010-07-29 2012-12-28 Fournier Lab Sa Derives de 15-desoxyspergualine pour le traitement et/ou la prevention des maladies inflammatoires oculaires
KR101695730B1 (ko) 2015-03-10 2017-01-12 하경훈 마늘꼭지 절단기의 절단장치
FR3050455B1 (fr) * 2016-04-26 2019-06-14 Temisis Derives amides des acides polycafeoylquiniques, procede de preparation et utilisations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5942356A (ja) * 1982-09-02 1984-03-08 Microbial Chem Res Found スパガリン関連化合物およびその製造法
DE3770680D1 (de) * 1986-04-04 1991-07-18 Microbial Chem Res Found Spergualinaehnliche verbindungen und ihr herstellungsverfahren.
US5061787A (en) * 1988-06-24 1991-10-29 Nippon Kayaku Kabushiki Kaisha Novel spergualin-related compounds and compositions

Also Published As

Publication number Publication date
CN1045431C (zh) 1999-10-06
HU218908B (hu) 2000-12-28
FR2698628B1 (fr) 1995-02-17
EP0600762B1 (fr) 1996-07-10
NO180483C (no) 1997-04-30
SK280286B6 (sk) 1999-11-08
TW311132B (enExample) 1997-07-21
RU2114823C1 (ru) 1998-07-10
FI935318A0 (fi) 1993-11-29
DE69303583T2 (de) 1996-11-21
CA2110437A1 (en) 1994-06-03
NO180483B (no) 1997-01-20
JPH06293728A (ja) 1994-10-21
CZ262293A3 (en) 1994-06-15
NO934338L (no) 1994-06-03
CN1095709A (zh) 1994-11-30
NZ250330A (en) 1995-06-27
DE69303583D1 (de) 1996-08-14
US5476870A (en) 1995-12-19
NO934338D0 (no) 1993-11-30
HK1000467A1 (en) 1998-03-27
FR2698628A1 (fr) 1994-06-03
HUT65782A (en) 1994-07-28
FI935318L (fi) 1994-06-03
CA2110437C (en) 1999-04-13
EP0600762A1 (fr) 1994-06-08
AU5188393A (en) 1994-06-16
HU9303406D0 (en) 1994-03-28
CZ284958B6 (cs) 1999-04-14
JP2945261B2 (ja) 1999-09-06
SK135793A3 (en) 1994-06-08
ZA938821B (en) 1994-06-30
KR940014435A (ko) 1994-07-18
GR3021269T3 (en) 1997-01-31
DK0600762T3 (da) 1996-11-11
KR100187328B1 (ko) 1999-05-15
UA39920C2 (uk) 2001-07-16
FI112211B (fi) 2003-11-14
AU664124B2 (en) 1995-11-02
ES2092263T3 (es) 1996-11-16

Similar Documents

Publication Publication Date Title
ATE140215T1 (de) 15-deoxyspergualin analoge verbindungen, verfahren zu ihrer herstellung und ihre verwendung als therapeutika zur unterdrückung der immunabwehr
DE59108707D1 (de) Verfahren zur Herstellung von Oxetanonen
AU586248B2 (en) (Meth)-acrylic acid esters and their use
ATE225348T1 (de) Substituierte azaindolylidenderivate und verfahren zu ihrer herstellung
ATE19513T1 (de) Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel.
ATE258925T1 (de) Verfahren zur herstellung von isocyanatverbindungen aus haloaminotriazinen und säurehalogeniden
DE69325262D1 (de) Vinylen-azaindolderivate und verfahren zu ihrer herstellung
ATE3771T1 (de) Dimethylphosphinyl-alkanphosphonsaeuren, ein verfahren zu ihrer herstellung und ihre verwendung als gipsabbindeverzoegerer.
DE69207429D1 (de) Verfahren zur herstellung von substituierten piperidinen
ATE90676T1 (de) Dioxyalkylenaryl-dihydropyridine zwischenprodukte zu ihrer herstellung, verfahren zu ihrer herstellung und ihre verwendung.
ATE134623T1 (de) Salicyl(thio)etherderivate, verfahren und zwischenprodukte zu ihrer herstellung
DE69208208D1 (de) Verfahren zur herstellung von gereinigtem naphthalendikarbonsäuredimethylester
DE69104220D1 (de) Verfahren zur Herstellung von direktkomprimierten, Cephalosporansäure Derivate enthaltendenTabletten.
ATE130845T1 (de) Verfahren zur herstellung von 3-amino-2- (het)aroyl-acrylsäurederivaten.
DE59206545D1 (de) Modifizierte Huminate, Verfahren zu ihrer Herstellung und Verwendung
ATE31928T1 (de) Acylamino-4-aza-1-adamantane, verfahren zu ihrer herstellung und ihre anwendung in der therapeutik.
DE3770037D1 (de) Dissymmetrische 1,4-dihydropyridin-3,5-dicarbonsaeure-derivate, verfahren zur herstellung und verwendung in therapeutik.
ATE193703T1 (de) N-benzylpiperazinverbindungen, verfahren zu ihrer herstellung und sie enthaltende zusammensetzungen
ATE175199T1 (de) Verfahren zur herstellung von 2-substituierten 5- chlorimidazol-4-carbaldehyden
ATE158576T1 (de) Alpha-aryl-alpha-hydroxy-beta- imidazolinylpropionsäureamide
DE69405507D1 (de) Zwischenprodukte zur Herstellung von Vitamin A und von Carotenoiden und Verfahren zu deren Herstellung
DK0656379T3 (da) Fremgangsmåde til fremstilling af polyurethangenstande fra uretonimin-baserede sammensætninger
ATE169961T1 (de) Verfahren zur herstellung von 2,5- dihydroxyphenylessigsäure
DE3868948D1 (de) 4,4-dimethyltetrahydropyr-2-on-derivate, verfahren zu ihrer herstellung und ihre verwendung zur synthese von pyretrinverbindungen.
ATE153995T1 (de) Cyclizierte analoge der fettsäurenmetaboliten, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee